Skip to content

Other

DEA-COCOAMPHODIPROPIONATE

48

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

An amphoteric surfactant containing diethanolamine (DEA) that is restricted in the EU due to nitrosamine formation potential.

DEA-cocoamphodipropionate is listed in EU Annex II/411 of the Cosmetics Regulation, meaning it is restricted due to the presence of diethanolamine (DEA). DEA can react with nitrosating agents to form N-nitrosodiethanolamine (NDELA), a suspected carcinogen. The EU requires that DEA itself is not used in cosmetic formulations, and ingredients that release DEA may also be subject to scrutiny. Maximum NDELA levels must be below 50 µg/kg in cosmetic products.

Skin benefits

  • Conditions skin and hair
  • Produces rich lather
  • Reduces irritation from other surfactants in blends

Known concerns

  • EU Annex II/411 restricted — DEA content raises nitrosamine formation concern
  • Suspected carcinogen (NDELA) on prolonged skin contact
  • Not recommended for leave-on products

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find DEA-COCOAMPHODIPROPIONATE in your products.

Scan any cosmetic product with LuxSense to see if it contains DEA-COCOAMPHODIPROPIONATE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.